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Abstract
Powerful new technologies for perturbing genetic elements have
recently expanded the study of genetic interactions in model
systems ranging from yeast to human cell lines. However, technical
artifacts can confound signal across genetic screens and limit the
immense potential of parallel screening approaches. To address
this problem, we devised a novel PCA-based method for correcting
genome-wide screening data, bolstering the sensitivity and speci-
ficity of detection for genetic interactions. Applying this strategy to
a set of 436 whole genome CRISPR screens, we report more than
1.5 million pairs of correlated “co-functional” genes that provide
finer-scale information about cell compartments, biological path-
ways, and protein complexes than traditional gene sets. Lastly, we
employed a gene community detection approach to implicate core
genes for cancer growth and compress signal from functionally
related genes in the same community into a single score. This work
establishes new algorithms for probing cancer cell networks and
motivates the acquisition of further CRISPR screen data across
diverse genotypes and cell types to further resolve complex cellular
processes.
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Introduction
Understanding the complex biological underpinnings of human
disease has long been a goal of network biologists (Baraba´si &
Oltvai, 2004; Baraba´si et al, 2011). Because genes vary in their role
and importance across diverse cell types, it has become increasingly
clear that characterizing tissue- and cell type-specific regulation of
chromatin accessibility (Roadmap Epigenomics Consortium et al,
2015; Breeze et al, 2016), chromosome looping (Javierre et al, 2016;
Mumbach et al, 2017), and gene expression (GTEx Consortium et al,
2017) will be central to developing a coherent understanding of
disease etiology. Differences in biological pathway importance
across tissues are especially vexing when modeling diseases such as
cancer that specifically exploit tissue-specific pathways and prefer-
entially acquire mutations to regulate them. Set against these chal-
lenges, the advent of new genetic perturbation systems scalable to
the size of the human genome offers an unprecedented opportunity
for the study of cancer cell networks and associated tissue-specific
signaling paradigms that do not exist in single-celled model organ-
isms like yeast (Gilmore, 2006; Fontana et al, 2010).
Genome-wide CRISPR screens (Shalem et al, 2014; Wang et al,
2014) have already enabled insights into cell trafficking (Gilbert
et al, 2014), drug mechanism of action (Shalem et al, 2014; Wang
et al, 2014; Doench et al, 2016), and infectious disease (Park et al,
2017; Gavory et al, 2018). Yet, while these methods allow every
gene to be perturbed and scored for its effect on a phenotype of
interest, this score does not provide direct insight into the logic of
the biological pathways involved in mediating the phenotype.
Instead, these screens report one-dimensional vectors of values:
Each gene falls on a single spectrum from dis-enriched to enriched.
Determining the cellular logic that integrates effects across genes
requires either specialized experimental design or extensive post-
processing of high-throughput screen data. Presently, there are three
prominent strategies for functionally characterizing genes genome-
wide based on observations from high-throughput screens: First, hit
genes are frequently enriched in curated gene sets that reflect
known biological processes or cellular components; second, combi-
nations of genetic perturbations can yield non-additive effects that
describe how information flows through sets of genes; and lastly,
pairs of genes that exhibit correlated effects across diverse cell lines
or conditions often lie in the same cell pathways. Enrichment in
curated gene sets can clarify the biological processes involved by
implicating cell pathways or compartments, but interpreting enrich-
ments can be extremely difficult (Rhee et al, 2008; Timmons et al,
2015) and new experimental methods have facilitated the pursuit of
the other strategies.
Combinatorial sgRNA platforms (Bassik et al, 2013; Kampmann
et al, 2015) disrupt multiple genes per cell to identify epistatic inter-
actions that can unmask gene logic. These platforms are the
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successors of double-knockout array technology used in yeast to
identify genetic interactions for 90% of all genes (Tong et al, 2004;
Costanzo et al, 2010, 2016). While these methods have the power to
directly test hypothesized genetic interactions, technological
constraints have limited individual combinatorial sgRNA studies to
measuring interactions for only a small fraction of all pairs of
human genes (Ogasawara et al, 2015; Wong et al, 2016; Han et al,
2017; Shen et al, 2017; Horlbeck et al, 2018). Ascertaining appropri-
ate gene pairs for such phenotyping is not trivial, especially for
synthetic interactions where neither genetic perturbation exhibits an
effect on its own, although algorithms to overcome this challenge
are under development (Medina & Goodin, 2008; preprint: Deshpande
et al, 2017). Interpretation of measured interactions is also compli-
cated by the fact that the extent to which genetic interactions persist
across cell types or samples is unknown.
Parallel screening designs approach the identification of interact-
ing genes in a fundamentally different manner. All genes of interest,
potentially comprising the entire genome, are screened in a diverse
panel of cell lines, and the perturbation effect sizes across these cell
lines are recorded as a gene perturbation profile for every gene
(Fig 1A and B). The distinct genetic and epigenetic features of each
cell line modify its susceptibility to disruption of pathways, orga-
nelles, or even individual protein complexes. In general, two genes
that have correlated gene perturbation scores across many cell lines
are inferred to be functionally related, with greater correlation
implying greater shared function, an observation first made in yeast
(Fraser & Plotkin, 2007). More recently, data from only 6 cell lines
sufficed to verify essential gene pathways (Hart et al, 2015);
however, a larger panel of 14 parallel AML line CRISPR screens
allowed more systematic validation of cancer metabolic and signal-
ing pathways (Wang et al, 2017). The publication of hundreds of
CRISPR screens in cell lines drawn from diverse cell lineage and
mutational backgrounds has invited even broader surveys of co-
essentiality (Meyers et al, 2017; Data ref: Meyers et al, 2017). One
study has dissected the composition of essential protein complexes
(Pan et al, 2018), another has leveraged the natural occurrence of
gene activating mutations to ascertain likely genetic interactions
(Rauscher et al, 2018), and other work accessible as a preprint has
focused on the organization of cancer growth pathways (preprint:
Kim et al, 2018). In all these cases, interactions identified from
correlated gene profiles operated on multiple levels of cellular regu-
lation, validating parallel screening as a powerful tool for recon-
structing cell networks.
While effective, parallel screening approaches require more
substantial post-processing of results than combinatorial screens.
Studies involving parallel screens are straightforward to design, but
technical variation in how the screens are performed as well as copy
number variation across cell backgrounds can confound the results
(Zhang & Lu, 2009; Aguirre et al, 2016). Recent work has shown
that copy number variation can underlie the strongest hits in
CRISPR-knockout screens, and multiple groups have proposed
corrective algorithms to confront this problem (Pommier, 2006;
Meyers et al, 2017; Data ref: Meyers et al, 2017; preprint: Wu et al,
2018). Additional heuristics aimed at increasing the quality of
genetic interactions identified from parallel genetic screens have
included discarding entire screens with noisy effect sizes, setting an
effect size threshold for correlating genes, and capping the number
of interactions per gene (Wang et al, 2017; preprint: Kim et al,
2018; Pan et al, 2018); however, reliance on these heuristics
prevents truly unbiased genome-wide analyses (McFarland et al,
2018). Furthermore, as the scale and diversity of published genetic
screens grow, so will the need for new statistical techniques that
can correct for technical variation while preserving even small
levels of true signal.
In this work, we develop a flexible, unsupervised approach for
removing confounding from parallel genome-wide CRISPR screens.
We apply this approach to the 436 CRISPR screens of Project
Achilles and compute corrected gene profiles for all reported genes.
We identify more than 1.5 million pairs of significantly correlated
co-functional genes, substantially more than reported by other stud-
ies. Finally, we detect functionally delineated gene communities and
characterize their specificity with respect to cell lineage and muta-
tional backgrounds. Using these gene communities, we provide new
insight into cancer cell network topology including scores for each
gene’s potential to drive a pathway important for cancer prolifera-
tion.
Results
Correcting for technical confounding found in parallel genetic
screen data
We first downloaded CRISPR screen gene summary data corrected
for copy number confounding from the Project Achilles data deposi-
tory (Meyers et al, 2017; Data ref: Meyers et al, 2017) and matched
RNA-Seq and mutation data from the Cancer Cell Line Encyclopedia
(CCLE) website (Barretina et al, 2012). The results of the CRISPR
screens form a matrix, where each row in the matrix serves as a
gene essentiality profile that summarizes the knockout phenotype of
the gene across the 436 cell lines (the columns of the matrix). As
reported by others, the degree to which two gene essentiality pro-
files (rows) are correlated reflects their functional relationship. This
functional relationship can reflect many gene–gene relationships,
including membership in the same metabolic pathway or protein
complex, and depends on the mutations present in the cell lines
tested (Fig 1A and B; Wang et al, 2017; Pan et al, 2018).
Because technical factors in the dataset could drastically skew
Pearson’s correlation values, we explored a large set of control
genes expected to have little to no phenotype in the context of
cancer proliferation: olfactory receptors [as classified by the
HUGO Gene Nomenclature Committee (HGNC)]. Some olfactory
receptors shared identical sgRNAs, and in these cases, we
retained only one olfactory receptor to avoid duplicate gene pro-
files. Within this set, all pairwise correlations were calculated
under the expectation that strong effect sizes would indicate tech-
nical confounding. Under a model of uniformly null phenotypes,
we would expect correlations to be tightly distributed around 0.
In fact, olfactory receptors often exhibited profiles that were
highly correlated across genetic backgrounds, strongly suggesting
the presence of technical confounding.
To investigate the unanticipated signal of essentiality in olfactory
receptors, we evaluated the covariance of the knockout growth
phenotypes across cell lines using principal components analysis
(PCA). We performed PCA on the matrix of growth defects from
each olfactory receptor (row) and cell line background (column;
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Fig 1C). The resulting principal components describe how likely
each cell line is to exhibit essentiality among olfactory receptors. If
the essentiality measurement of each olfactory receptor was being
driven by gene function or chromosomal locus, these profiles—a
single number per cell line—would be expected to be poorly predic-
tive genome-wide. However, we found that the top five principal
components explained significantly more variance than expected by
permutation testing, with over half of the variance explained by the
first principal component alone (Fig EV1A). We repeated this
approach with a curated set of nonessential genes in place of olfac-
tory receptors and reproduced the loadings on the first principal
component, demonstrating that signatures are robust to choice of
control gene set (R = 0.92, Fig EV1B).
The loadings on the first principal component, which again
explained most of the variance in olfactory receptor scores, were
highly correlated with the variance in effect size estimates for olfac-
tory receptor genes for each cell line (R = 0.89, Fig EV1C). One
possibility is that regressing on the variance of each cell line acts as
a technical correction, re-centering and scaling the effect sizes in a
manner similar to that performed in a similar study (Rauscher et al,
2018) and recommended in a recent article (McFarland et al, 2018).
In this case, our scaling would roughly equalize variance in biologi-
cal effect sizes among negative control genes. Alternatively, some-
thing that would be well captured by a single number per cell line
such as cell health or sensitivity to double-strand breaks would also
be consistent with prior work investigating CRISPR screen
specificity and could produce the same relationship with variance in
cell line effect sizes (Morgens et al, 2017; Rosenbluh et al, 2017). In
this case, one might expect mutational status in certain genes to
predict the loading on cell line signatures, but the presence of
coding or loss-of-function mutations in all recorded genes was not
associated with principal component loadings (Wilcoxon rank-sum
test, q < 0.1 for all genes). In any case, re-centering and scaling is
not likely to underlie the four other orthogonal candidate signatures
of confounding.
To produce an improved dataset, we first subtracted all five
candidate signatures of confounding from each gene’s essentiality
profile (Fig 1C). Using these corrected gene essentiality profiles, we
again computed the correlation of all pairs of genes. In many cases,
as seen for peroxisome genes, learned relationships before and after
correction appeared unchanged, but in others, as seen for spliceo-
some scaffold proteins, previously unremarkable sets of genes
appeared tightly related (Fig 2A and B). Pairs of olfactory receptors
that were persistently correlated after correction were often in very
close physical proximity on chromosome arms. As observed previ-
ously (Meyers et al, 2017; Data ref: Meyers et al, 2017), physical
proximity often increases the rate of correlation even after CERES
copy number correction (Fig EV1D), suggesting either that there are
differences in local toxicity to dsDNA breaks or that copy number
variation confounding persists at short physical distances.
Putting aside potential confounding due to physically proximal
genetic perturbations, we observe other clear advantages to working
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Figure 1. Detecting co-functional interactions from parallel genetic perturbation screens.
A, B Diversity in (A) mutational background and (B) pathway activity produce correlated gene essentiality profiles of knockout effect sizes for members of the same
pathway. Cell lines with inactivating mutations in or downregulation of biological pathways are impervious to gene knockout. Discrete and continuous differences
across cell lines can thus be summarized by a correlation coefficient.
C Nonspecific sources of variation across cell lines can be removed by learning principal components from a set of control genes that should not contain biological
signal and subtracting these components from the raw gene profiles.
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with corrected gene essentiality profiles. By creating cell line profiles
from all gene knockout effects and comparing the correlations for
every pair of cell lines before and after correction, we observed
marked boosts in accuracy for predicting shared primary tissue
(AUC increased from 0.667 to 0.841) and for predicting secondary
tissue (AUC increased from 0.637 to 0.788; Figs 2C and EV1E). At
the same time, the median cell line profile correlation dropped from
~0.85 to nearly 0 following correction (Fig EV1F), suggesting that
mean effect sizes per gene are lost in the correction process,
although this does not affect calling of correlated gene pairs.
Identification of over 1 million co-functional interactions from
corrected gene essentiality profiles
To detect gene pairs with significantly correlated gene essentiality
profiles, or “co-functional” genes, we derived P-values for the
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Figure 2. Constructing a set of co-functional genes from all pairs of human genes.
A Demonstration of co-functional gene calls before and after correction for three example gene sets: olfactory receptors that exhibit nonspecific interactions in the raw data,
peroxisome genes that show persistent co-functionality before and after correction, and spliceosome complex members that show correlation only after correction.
B Correlation for two small nuclear ribonucleoproteins, SNRPD1 and SNRPD3, that required for splicing, before and after correction of effect sizes from 436 cell lines. Fit
lines are from linear regression.
C Area under the receiver operating characteristic (ROC) curve for using cell line profiles to determine whether two cell lines share the same primary tissue of origin.
Cell line profiles (the vector of effect sizes across all genes for each cell line) are more correlated among cancers of the same type following correction.
D The distribution of pairwise correlations of corrected gene essentiality profiles genome-wide is greatly skewed to more positive values compared to pairs of olfactory
receptors. Significance thresholds indicated with triangles.
E Highly expressed essential genes regularly have on the order of one thousand co-functional interactions.
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observed correlations from an empirical null distribution. To build
the distribution, we used the pairs of olfactory receptors described
above as a background set, assuming that these receptors would not
affect cancer growth. Correlations across all pairs of olfactory recep-
tors were roughly normally distributed and centered at zero.
Observed correlations across corrected gene essentiality profiles
genome-wide for all other genes greatly exceeded expectation from
the null model (Fig 2D). Thus, we assigned p-values for every
observed correlation, whether positive or negative, using a normal
distribution fit to the correlations of pairs of olfactory receptors.
Across all 17,634 genes tested, 1,528,726 co-functional interactions,
equal to 0.98% of all possible pairs of genes, met a false discovery
rate of 10%. A similar procedure on raw gene essentiality profiles
yielded only 30,761 interactions. Downsampling of the number of
cell lines included in the analysis shows that more cell lines tighten
the null distribution and increase power to discover co-functional
interactions (Fig EV1G).
We immediately noted that highly expressed essential genes
(Hart et al, 2014) generally possessed hundreds of co-functional
interactions (Fig 2E). One might expect universally essential genes
to lack identifiable co-functional gene partners, but this was rarely
the case. Furthermore, we confirmed past reports (Barretina et al,
2012; Hart et al, 2015; Wang et al, 2015) that genes that are
either highly or invariantly expressed across tissues on average
possess greater knockout effects (Fig 3A). Remarkably, this holds
true not only across cell types, but even in the context of expres-
sion data from a panel of lymphoblastoid cell lines (LCLs; Fig 3B;
Pickrell et al, 2010), suggesting that broad mechanisms of gene
regulation and not tissue specificity are responsible for the trend.
As reported previously (Wang et al, 2015, 2017; Pan et al, 2018),
differences in essentiality across genes thus appear quantitative
and not strictly binary in each cell line. To facilitate exploration
of our co-functional gene dataset, we have developed a shiny app
that visualizes all genes co-functional to the query gene with
added functionality for overlaying interactions from STRING,
published CRISPR screens, or custom files containing scores per
gene.
Gene co-functionality captures variation in drug susceptibility
across cancer cell lines
Past analyses (Hart et al, 2015; Wang et al, 2017) explored cell
signaling in a restricted number of cancer cell lines (Fig 4A).
With 436 samples, a much broader view of the diversity of
signaling is possible, including differences across diverse cell
types of origin. For MAPK and p53 pathways, the profiles of
many genes hew closely to the TP53 status of the cancer,
producing two well-separated clusters with predictable effect
sizes across cell lines (Fig 4B). Excluding a handful of outliers,
TP53 loss-of-function mutants (Barretina et al, 2012) do not
respond to TP53 or MDM2 knockout or treatment with Nutlin-3,
an anti-MDM2 drug. TP53 wild-type cells, in contrast, grow
following TP53 knockout, die following MDM2 knockout, and
exhibit slowed growth following treatment with Nutlin-3. These
observations suggest that negative regulation of TP53 is robust
across cancer types, at least for its strongest co-functional genes.
For example, two proposed drug targets, the deubiquitinase USP7
(Gavory et al, 2018) and phosphatase PPM1D (Ogasawara et al,
2015), consistently mirror TP53-knockout phenotypes, proving
themselves robust to cell lineage and mutations in other biologi-
cal pathways.
The essentiality of BRAF and its co-functional gene partners
paints a similar picture (Fig 4C), primarily with respect to mela-
noma cell lines. The knockout effects of genes co-functional to BRAF
depend considerably on BRAF V600E status, with BRAF V600E lines
especially sensitive to BRAF, MAP2K1, and MAPK1 knockout, which
another group independently reported (preprint: Kim et al, 2018).
Thus, there is strong evidence that genes co-functional to central
cancer growth genes mediate their essentiality through their
involvement in those genes’ pathways.
Incorporating drug–gene associations into gene networks
By correlating the maximal activities of anticancer compounds in
each cell line to the gene profiles derived from knockout effects, it is
possible to test for drug–gene associations and then combine drugs
and genes into a single network (Figs 4D and EV2). To explore
examples of drug–gene interactions, we examine interactions with
genes encoding the four ErbB proteins, well-characterized receptor
tyrosine kinases (RTKs) that act upstream of PI3-K and MAPK path-
ways and complex with each other to mediate growth signaling
(Medina & Goodin, 2008). ErbB family members are highly drug-
gable and have been targeted by erlotinib, an anti-EGFR drug, and
lapatinib, a dual anti-HER2, anti-EGFR drug. We observe that lapa-
tinib-sensitive cell lines are sensitive to knockout ErbB family
members (EGFR, ERBB2/HER2, and ERBB3/HER3), whereas erlo-
tinib-sensitive lines are associated with sensitivity to EGFR and no
other ErbB member.
For each drug compound, we tested the enrichment of KEGG
terms among drug–gene associations. The most enriched term for
each drug tended to confirm known biology (Fig 4E): Nutlin-3
upregulates p53 signaling, PLX4720 treats melanoma, and sora-
fenib modulates MAPK signaling. AZD6244 targets MAPK signal-
ing pathways important for melanoma, explaining the extreme
enrichment for “melanoma” genes. Enrichment for SNARE
proteins for lapatinib associations suggests that RTK receptor
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trafficking is influencing the drug–gene network. Interestingly, L-
685458, a gamma-secretase inhibitor, was most enriched for
proteasome genes. There is debate in the literature whether
gamma-secretase inhibitors, including L-685458, mediate their
cancer-killing effects via gamma-secretase or by the proteasome
(Clementz & Osipo, 2009). Cancer models often lack growth
phenotypes when treated with gamma-secretase inhibitors,
suggesting that these inhibitors hit multiple pathways such as the
proteasome. In this panel, it is thus plausible that proteasomal
inhibition is the most important factor.
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Enrichment of co-functional genes in curated gene set databases
To evaluate the extent to which co-functional genes reflect distinct
kinds of functional relationships, we calculated the global enrich-
ment of co-functional gene relationships across gene sets main-
tained by the Molecular Signatures Database (Subramanian et al,
2005). Curated gene sets consistently contained more co-functional
pairs of genes than expected by chance: twofold enrichment for
genes annotated with the same biological process or molecular func-
tion, more than threefold for cellular component, and fourfold for
KEGG pathways (Fig 5A; Ashburner et al, 2000; The Gene Ontology
Consortium, 2017). With respect to reconstituting curated gene sets,
our co-functional gene dataset exhibits lower enrichment than
protein mass spectrometry but contains over 100 times more poten-
tial interactions (Rolland et al, 2014). Approximately one-third of
biological process and 60% of cellular component terms were
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Figure 5. Comparison of gene co-functionality to diverse gene annotation databases.
A Pairs of genes annotated with the same Gene Ontology term (BP = biological process, MF = molecular function, CC = cellular component) or Kyoto Encyclopedia of
Genes and Genomes (KEGG) pathway are enriched for co-functional interactions. Pairs of genes with annotated interactions from STRING, especially high-confidence
(> 500) interactions, are also enriched. Pairs of genes belonging to the same protein complex as curated in the Comprehensive Resource of Mammalian Protein
Complex (CORUM) core complex database exhibit the greatest enrichment.
B Percent of gene sets containing at least 5 pairs of co-functional genes and, among those, the fraction that are enriched for co-functional interactions above degree-
matched random graphs.
C Rates of co-functional gene calls for gene pairs binned by their path length in the STRING experimentally derived PPI network. “Inf” (infinite) refers to genes that lie
in separate components.
D Co-functional call rates among CORUM protein complex edges split by complex size. The binomial expectation for the number of edges called as co-functional is
shown in gray. Co-functionality rates per complex are bimodal and greater for large protein complexes.
E Extension of (D) to larger protein complexes, with the number of edges expressed as the fraction of all possible edges in the complex, equal to ð n
2
Þ. The area of each
point reflects the number of multiple protein complexes with the same complex size and edge density. Complexes with fewer co-functional genes than expected
according to the average rate are shown below the dashed line. The 90% binomial confidence interval for random co-functionality calls given the average rate is
shown in gray. Large complexes again exhibit more co-functional interactions.
F Reconstruction of the Mediator complex from gene co-functionality, shown in a force-directed graph. Subunits in the same domain (head, middle, tail, or CDK
effector) of the complex are more likely to be co-functional than subunits in different domains. The area of each gene node corresponds to its loading on the first
principal component of the corrected gene essentiality profile matrix.
G Mediator subunit knockout effect sizes in each cell line can be summarized by a “Mediator score”, the first principal component score for each cell line, plotted
against the knockout phenotype of specific genes (first four facets) or a pool of all genes in the complex (bottom row).
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enriched above levels seen for matched random networks (Fig 5B,
see Materials and Methods). We also performed gene set enrichment
on genes with no co-functional gene edges and found that underrep-
resented pathways were mostly limited to genes involved in lineage-
specific (e.g., muscle) development and differentiation (Fig EV3A).
Despite these blind spots, we conclude that many diverse biological
pathways, not simply pathways typically associated with essential-
ity, contribute to gene co-functionality.
Co-functional gene edges overrepresented among protein–
protein interactions
Relative to curated gene sets, reported protein–protein interactions
exhibited greater enrichment of co-functional genes. This was true
for large-scale repositories of experimental data, as curated by the
STRING consortium (Szklarczyk et al, 2015) (14-fold among inter-
actions above 500 confidence), and for well-studied protein
complexes, as curated in the CORUM core complex resource (Ruepp
et al, 2010) (almost 30-fold for proteins in the same complex). In
fact, we validated the majority (53.9%) of gene pairs in CORUM
core complexes (N = 48,408) as co-functional genes (binomial test
P < 1e-300).
We next explored how STRING interactions related to our set of
co-functional genes in more detail. 13% of co-functional interactions
were present in the STRING database of protein–protein interac-
tions, compared to 3% of all pairs of genes. The probability of a
STRING interaction being called varied depending on the type of
annotation and in accordance with its confidence (Fig EV3B). 11%
of low-confidence (score 1–150) experimentally derived STRING
interactions were among our co-functional interactions, compared
to 88% of high-confidence (score 900-1000) STRING interactions.
Likewise, only 4% of low-confidence co-expression transferred
STRING interactions were among our co-functional interactions,
compared to 72% of high-confidence STRING interactions. Nonethe-
less, all categories were enriched for co-functional genes above the
global average of 0.98%.
Interestingly, we find only a small fraction (~2%) of co-func-
tional genes to be negatively correlated. Among pairs of genes in
STRING with detailed functional annotations, 32% of the highest
confidence (> 900) activating interactions were called, in contrast to
7.8% of highest confidence inhibiting interactions (Fig EV3C). High-
confidence (score > 700) activation, catalysis, reaction, and binding
interactions were overwhelmingly positively correlated (99.4%,
99.3%, 99.4%, and 99.5% of correlations above zero, respectively,
Fig EV3D). While the statistically significant correlations among
inhibiting interactions might be expected to be broadly negative,
this was not the case: Only 1.8% of all correlations were negative.
We found that 61% of STRING interactions annotated as inhibiting
were also annotated as activating or catalyzing and could predomi-
nantly operate in a cooperative rather than inhibitory manner, but
even among pairs of genes exclusively annotated as sharing an inhi-
bitory relationship, only 36% were negatively correlated. This
dearth of anti-correlated co-functional genes is consistent with the
observation by Wang et al (2017) that anti-correlated co-essential
genes are less often detected. Thus, pooled CRISPR-knockout
screens, even with diverse panels of cell lines, may have low sensi-
tivity for detecting inhibitory relationships across pairs of genes, or
negative regulation more broadly.
Because our reported number of co-functional interactions
exceed the estimated number of human gene pairs that physically
interact (Stumpf et al, 2008; Venkatesan et al, 2009) by as much as
10-fold, we explored the potential underpinnings of co-functionality
signal in greater detail. In total, only 12% of co-functional genes are
annotated by any co-expression/experimental study, suggesting that
physical interactions among proteins and gene co-regulation explain
a minority of co-functional interactions. To evaluate the extent to
which co-functional genes could be linked indirectly by cascades
through the human interactome, we calculated the rate of gene co-
functionality as a function of the path length dictated by the STRING
database. Pairs of genes separated by 2–4 experimentally derived
STRING edges had consistently higher rates of co-functionality
compared to pairs of genes in separate components of the network.
Among STRING interactions of confidence > 700, genes with one
intermediate gene, or path length 2, were enriched 30-fold (Fig 5C).
The functional pathways we identify are likely mediated in part by
intervening protein interactors, in additional to metabolic pathways
and direct physical interactions.
Characterizing co-functionality among members of
protein complexes
Across CORUM core complexes, we also observe that the number of
co-functional interactions per complex deviates far from expected
assuming independent draws from a binomial distribution. In fact,
oftentimes all or none of a protein complex’s members were labeled
co-functional (Fig 5D and E). Complex size also played a role, as
60% of core complexes with 5 or fewer members contained no co-
functional genes, whereas 95% of complexes with more than five
members exceeded the average rate of co-functional interaction
calls. Protein complex essentiality appears to explain some of this
bimodality: Co-functionality is rarely detected among CORUM core
complex members that only weakly affect growth, whereas CORUM
core complexes that strongly affect growth form nearly complete
graphs of co-functionality (Fig EV3E), as seen for mitochondrial and
cytosolic ribosomes, the proteasome, U2 snRNP, and RNA poly-
merase II complexes.
Although the rate at which we identified the members of a
protein complex co-functional varied according to the knockout
growth phenotype, we identified other factors that guided which
of a complex’s members were co-essential and which were not.
The Mediator complex, a transcriptional coactivator that has been
previously examined using a similar parallel screening analytical
approach (Pan et al, 2018), serves as an example. Although
knockout of every Mediator complex member is associated with
impaired growth, we called fewer than half of the pairs of genes
comprising the Mediator complex co-functional (Fig 5F). The
network of co-functional gene edges describing the members of
the Mediator complex in fact mirrors the three-dimensional struc-
ture and function of the complex; gene knockouts cluster by their
topology, divided into head, middle, tail, and effector module
(Yin & Wang, 2014). We also summarized cell lines by running
PCA on the matrix of cell lines by Mediator complex members
and assigning the first PC score of each cell line as its “Mediator
score”. This score integrates the 30 Mediator member knockout
effect sizes into a single number reflecting the growth defect asso-
ciated with Mediator loss of function. The Mediator score can
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predict the effect of knocking out arbitrary Mediator complex
members (Fig 5G) but does so independently of protein domain-
specific effects.
Gene communities in the cancer cell network offer insight into
cancer proliferative processes
To examine the distribution of co-functionality genome-wide and
nominate candidate core genes for cancer growth, we performed
community detection to partition all genes into separate communi-
ties (Fortunato, 2010). Every gene was assigned to one of 2,857
separate communities, including 2,978 singleton genes with no co-
functional genes and 562 small communities with fewer than 8
genes. Because singleton and very small gene communities harbor
few edges and are better suited to gene- and not community-centric
approaches, we focused on the 326 communities with at least 8 gene
members (Fig 6A).
We first enumerated the 719 COSMIC census genes in each
community (Forbes et al, 2017) and found that over one-third of
gene communities (126/326) contained at least one census gene,
illustrating the extreme diversity of pathways that cancers can
manipulate to maximize cellular proliferation. However, certain
gene communities possessed many more census genes than
expected, including communities containing TP53, EGFR, KRAS, and
BRAF. Finally, over half of the clusters (206/326) were significantly
enriched for at least one Biological Process term or KEGG pathway
at a false discovery rate of 10%.
The largest community we identified was densely connected
(12% of all pairs connected) and encompassed numerous core
essential processes identified by KEGG, including the spliceosome,
the ribosome, the proteasome, cell cycle, RNA polymerase, and
mismatch repair (Fig 6B). A smaller, slightly denser cluster (13% of
all pairs connected) contained genes required for mitochondrial
function and aerobic respiration. Genes lacking any pathway anno-
tations for the most part were not enriched in any gene communities
but were significantly dis-enriched in these core growth communi-
ties (Fig EV4).
Gene communities varied substantially in the breadth of their
encapsulated functions. Some communities derived from specific
cancer pathways, such as the community containing EGFR, which
simultaneously captured signaling from related ErbB proteins and
the role of cell adhesion and tissue migration in EGFR-dependent
transformation (Fig 6C) (Lindsey & Langhans, 2015). Other clusters
reflected very specific cell functions or compartments, as in the case
of the peroxisome.
In the peroxisome community, 34 Gene Ontology terms were
statistically enriched, ranging in size from 12 to 415 genes. Enriched
gene sets primarily derived from peroxisomal transport and fatty
acid metabolism. Although these are not conceptually similar path-
ways, they both relate to the core function of peroxisomes, which
are variably essential across the cancer cell lines. In the context of
cancer proliferation, abstracting fatty acid metabolism away from
peroxisomal transport genes, as done in the Gene Ontology data-
base, may ignore the reality that these processes are functionally
inseparable.
Another community (Fig 6D) contains the genes underlying
hereditary multiple osteochondromas, a rare Mendelian disorder.
These genes, EXT1 and EXT2, are known to act in the
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Figure 6. Gene communities and network topology in cancer cell
networks.
A Consolidation of genes into > 200 communities using de novo
community detection. COSMIC census genes frequently cluster in the
same gene communities beyond expected by chance (in gold) but are
otherwise widely dispersed throughout the network (in green). Nodes
representing communities are sized by number of constituent genes. The
largest community contains over 1,000 core essential genes (labeled
“Transcription & translation”). Select gene communities are labeled by
enriched annotations and/or prominent cancer-associated genes.
B Distribution of gene communities by mean knockout effect size of
community members and co-functional edge density. “Respiration” and
“Transcription & translation” from (A) are both broadly essential and
densely connected.
C, D Depictions of the EGFR and EXT1 gene communities. Size of the gene
nodes reflects loading on the first principal component among
community members. Gene symbols that are members of selected
enriched gene ontology terms are labeled.
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polymerization of the glycosaminoglycan heparan sulfate, a known
cofactor for FGF signaling (Ornitz & Itoh, 2015). How EXT1 loss
leads to cancer is poorly understood (Bove´e, 2008); nonetheless,
eight other known aminoglycan synthesis genes participate in the
same gene community. Also present are fibroblast growth signaling
genes FGFR1, FRS2, and NDST1. GRB2 and PTPN11 are not in the
same gene community but are linked to gene community members
by additional co-functional interactions. One possibility is that every
member of the aminoglycan synthesis pathway influences cancer
proliferation by ultimately making heparan sulfate available to
upregulate FGF pathways. If true, the number of genes that could
potentially modify cancer proliferation via FGF signaling is much
larger than currently appreciated, expanding from EXT1 and EXT2
to all aminoglycan synthesis genes.
Gene network centrality adds another layer to gene function
We next examined the network topology within and across gene
communities. Because core growth genes would dominate strength
or degree calculations for most genes, we quantified the centrality of
every gene using the closeness of each gene within its prescribed
community. The closeness of a gene is the reciprocal of the sum of
the shortest distance via co-functional gene edges from that gene to
every other gene in the network. By calculating this metric within
communities, we obtain a local centrality measure that gives insight
into a diverse range of gene functions.
As a measure of centrality in the cell network, closeness added
information not captured by other gene properties such as essential-
ity or expression. Overall, COSMIC census genes did not differ in
closeness compared to other genes (Wilcoxon rank-sum P > 0.05),
nor did they differ substantially in their average knockout growth
phenotype. However, genes annotated as germline cancer genes
scored much higher in closeness than somatic cancer genes (Fig 7A,
Wilcoxon rank-sum P = 7e-9). In fact, gene closeness surpassed
gene expression level or knockout growth phenotype in accuracy for
ascertaining somatic from germline cancer genes (Fig 7B). Closeness
was slightly greater for genes suspected to be subject to strong puri-
fying selection via population genetic data (high pLI genes; Lek
et al, 2016), but high RNA expression level was more predictive of
high pLI status than closeness (Fig EV5A). We also observed that
genes linked to unfavorable prognoses in cancer patients exhibited
greater closeness in gene communities, but that genes linked to
favorable prognoses did not (Fig 7C; Uhlen et al, 2017). In all, we
linked high closeness genes to oncogenes and germline cancer
processes, complementing broad patterns of high expression and
essentiality for cancer drivers.
To summarize cancers by gene community activity, we again
performed principal components analysis—this time separately for
each gene community (see Materials and Methods)—and recorded
the first PC score for each cell line. This score reduces the dimen-
sionality of the gene profiles from the size of the gene community
down to a single number, which we term the community score. One
benefit of scoring communities as opposed to individual genes is
that the shared function of a gene community can be ascertained
while avoiding the measurement noise or alternate signals associ-
ated with individual gene knockouts.
We first explored how community score varied by cell lineage
and confirmed that cancer cell lineages dependent on particular
growth pathways were associated with extreme scores for the corre-
sponding gene communities. For example, it was often possible to
classify the lineage of glioblastoma, neuroblastoma, small-cell lung
cancer, melanoma, and pancreatic- and kidney-derived cancers by
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Figure 7. Topology and cell type specificity of cancer networks.
A Boxplot of closeness for genes annotated as germline cancer genes, somatic
cancer genes, or both. Significant by Wilcoxon rank-sum test. Upper
comparison *P = 7e-9; lower comparison *P = 7e-4.
B ROC curve showing how centrality (measured by closeness in the gene
community) separates germline from somatic cancer genes in the COSMIC
gene census more accurately than either growth knockout phenotype or
expression.
C Genes associated with unfavorable prognoses as found in the Human
Protein Atlas Pathology database have greater closeness within gene
communities, left. The same is not true for genes associated with favorable
prognoses, right.
D NF1 gene community knockout phenotypes and the NF1 aggregate
community score calculated from the first principal component of member
genes shows that perturbation of the community by CRISPR knockout
almost always occurs in NF1-WT glioblastoma cell lines but only rarely in
other cancers. P < 0.05 for all within-glioma comparisons.
E KRAS community scores demonstrate that dependence on constitutively
active (mutant) KRAS drives community organization, independent of
tissue, but is uniformly present across pancreatic cancers.
Data information: (A, C, D) Boxes reflect IQR, and lines reflect 1.5 times the IQR.
There are no replicates. Data annotations of cell type are as described in the
Meyers et al data depository (Meyers et al 2017; Data ref: Meyers et al 2017).
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virtue of their especially extreme community scores (Fig EV5B),
analogous to others’ findings (preprint: Kim et al, 2018). Interest-
ingly, we found that communities associated with cell lineage iden-
tity (see Materials and Methods) were three times more likely to be
enriched for COSMIC census genes than gene communities with no
associations (Fisher’s exact test P = 2e-8), consistent with the inter-
pretation that cancers from different cell lineages target different
growth pathways to maximize growth.
Diversity of cell line panel expands the scope of detectable cell
signaling paradigms
In some cases, cell lines of a specific lineage and mutational back-
ground were required to uncover cancer-relevant growth pathways.
The gene community containing the tumor suppressors NF1 and
SPRED1 illustrates this phenomenon (Fig EV5C). In the germline,
one NF1 loss-of-function allele causes the Mendelian disorder neuro-
fibromatosis type 1 (Gutmann et al, 2017). Similarly, loss of func-
tion of SPRED1 causes Legius syndrome, which can be confused
clinically with neurofibromatosis type 1 (both genes act upstream of
RAS signaling). In the panel of cell lines from Project Achilles,
glioma cell lines consistently exhibit the largest effect sizes for
community members NF1, SPRED1, and SOS1. Yet, even among
glioma cell lines, only those that lack a preexisting NF1 loss-of-func-
tion event exhibit large differences in sensitivity to gene knockout of
community members (Fig 7D). The differences across these genes
are well summarized by NF1 community scores, where glioma cell
lines with intact NF1 consistently score above glioma cell lines with
NF1 loss of function (Wilcoxon rank-sum P = 0.005). In the case of
non-glioma cell lines, NF1 community scores rarely deviate from
the mean and do not vary by NF1 mutation status (Wilcoxon rank-
sum P > 0.05).
While extreme community scores often occur in distinct cell
lineages, sensitivity to perturbation of gene communities can often
be accessed across multiple lineages. For example, perturbations
of the KRAS gene community are strongly associated with strong
fitness effects in pancreatic and colorectal cancers, but also exhibit
apparent effects in cell lines derived from other lineages. In
general, extreme KRAS community scores indicate the presence of
mutant, constitutively active KRAS (Fig 7E), with pancreatic and
colorectal cancers very likely to acquire such mutations due to
inherent tissue-specific cancer biology. In the Project Achilles
panel, all pancreatic cancers harbor KRAS-activating mutations,
while ovarian cancers infrequently do. This difference in muta-
tional status explains the difference in KRAS community scores
between pancreatic and ovarian cancers more accurately than cell
lineage and stands in contrast to the NF1 gene community exam-
ple where both a specific lineage and mutational status were
important characteristics.
Discussion
This work demonstrates the power of unsupervised statistical tech-
niques for correcting gene profiles constructed from parallel screen-
ing datasets. We show that technical confounding is pervasive
across CRISPR-knockout screens, but that highly active sgRNA
libraries and extensive data preprocessing steps can expand the
quantity and quality of interactions called from correlated gene pro-
files, whether or not interactions are mediated directly by protein–
protein interactions (Fig 8). When screening for hit genes that
modify a phenotype of interest, it is already considered best practice
for sgRNA libraries to contain “safe-targeting” sgRNAs that target
non-genic regions to correct for the toxic effects of DNA cleavage
(Morgens et al, 2017). We provide evidence that sgRNA off-target
effects can cause both false-positive and false-negative interactions,
and, by exploiting a set of control genes with a very low prior of
having an effect on the screen phenotype, we can correct these
confounding signatures. In the future, more comprehensive sets of
control sgRNAs may further improve modeling of confounding
across genomic regions of variable copy number, sequence content,
and chromatin accessibility.
Although some biological pathways can be readily detected using
a relatively small number of genetic screens for cancer growth, a
comprehensive mapping of cell networks will require much more
diverse panels of screens. In multiple cases, we detected certain
pathways that were active only in specific cell lineages or muta-
tional backgrounds. Among screens currently available, inhibitory
relationships among genes are only rarely detected. Finally, gene
knockouts that lack a growth phenotype in the available cell lines
cannot be incorporated into cell networks at all. These findings
argue for collecting screen data (a) for samples of cells with diverse
mutational and cell lineage backgrounds and (b) across diverse
screening conditions. The use of activating (CRISPRa) screens might
also improve detection of antagonistic gene pairs. Parallel screens in
the same cell lines for cancer phenotypes other than growth, such
as invasiveness or cell size, would complement existing data on
proliferation, but screening other phenotypes, such as phagocytosis
or sensitivity to oxidative stress, offers a way to improve the rich-
ness of sparse gene profiles. As more screening data become avail-
able that differ by screening phenotype, laboratory, manner of
perturbation (CRISPRi/a, base editing, inducible systems), and
sgRNA library, quality control for parallel screening techniques will
become increasingly critical.
Ligand-receptor
Modification
Metabolism
Co-complex
Regulation
Figure 8. Co-functional gene relationships.
Co-functionality learned from correlations among gene profiles broadly extends
to gene–gene relationships from physical interactions like ligand–receptor
interactions, co-complex formation, or post-translational modification to
conceptual relationships like gene regulation and shared metabolic pathways.
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Maps of cancer cell networks drawn using co-functional interac-
tions are assuredly detailed, but parallel screening approaches come
with distinct limitations. First, the co-functional interactions we
report obscure the distinction between direct and indirect interac-
tions as well as the directionality of information flow in signaling
processes. De novo methods to call gene communities might cluster
genes into a smaller set of modules, but the manner by which genes
in the same module work together remains difficult to infer. One
open question specific to the field of parallel screening is whether
interactions identified by double-knockout screens, particularly
synthetic interactions, can be predicted from co-functional interac-
tions identified in data collected from other cell lines. Also unknown
is the extent to which gene communities learned from one pheno-
type are the same communities underlying other phenotypes. Yet,
information theoretic models and orthogonal genome-wide profiling
data (e.g., RNA-Seq, ATAC-seq) promise to expand what can be
learned from genome-wide perturbation data. Regardless, engineer-
ing additional pre- and post-processing computational methods for
genome-wide perturbation data are likely to advance progress
toward a comprehensive understanding of cell network logic.
Materials and Methods
Calling co-functional interactions from CRISPR screening data
Project Achilles gene-level effect sizes (version 18Q2), the lists of
217 highly expressed genes and 927 nonessential genes from Hart
et al, and sgRNA sequences were downloaded from Meyers et al’s
data depository (Meyers et al, 2017a; Data ref: Meyers et al, 2017b)
for further processing.
To correct cell line-specific Cas9 toxicity, nonspecific cell line
signatures were generated from olfactory receptor gene essentiality
profiles. The HGNC olfactory receptor gene list was downloaded
from the HGNC website (https://www.genenames.org/cgi-bin/ge
nefamilies/set/141). The full list of olfactory receptor gene symbols
was intersected with gene symbols present in the gene-level statis-
tics. Some sgRNA sequences were not unique among olfactory
receptors; in these cases, one olfactory receptor was selected at
random and any olfactory receptors with duplicate sgRNA were
discarded. The resulting matrix of 250 olfactory receptors by 436 cell
lines was transposed and subjected to PCA using the prcomp func-
tion in R. The same procedure was applied to 100 permutations of
the same matrix by shuffling effect sizes within columns (cell lines).
For the first five PCs, the proportion of variance explained per PC
for the true matrix exceeded that of all permutations and were
deemed signatures of nonspecific toxicity.
Gene essentiality profiles were projected onto the principal
components identified as nonspecific and converted back to the
original dimension via matrix multiplication, and the difference of
matrices was taken as a set of corrected gene essentiality profiles.
In contrast to the original, frequently positively correlated gene
essentiality profiles, correlations among corrected gene essentiality
profiles for olfactory receptors resembled a normal distribution
centered at zero. To establish a null distribution, the above steps
were repeated with fivefold cross-validation and the mean squared
correlation of olfactory receptor gene pairs across all folds was
calculated as the standard deviation, with mean 0 (Fig 2D). This
process was repeated with curated nonessential genes and yielded a
22% narrower standard deviation. P-values were assigned to all
human gene pairs using this normal distribution via the pnorm func-
tion in R, and hits at a 10% FDR were identified as co-functional
interactions.
Using the same correlation cutoff for gene essentiality profiles,
co-essential gene hits were compared to co-functional genes within
three sets of genes: Gene Ontology “spliceosomal complex assem-
bly” genes (a category with surprisingly few correlated gene essen-
tiality profiles), Gene Ontology “peroxisomal transport” genes (a
well-circumscribed set of co-essential genes), and olfactory receptor
genes with co-functional degree of 12 or greater. In general, the
number of co-functional interactions, or degree, varied considerably
across all genes. Highly expressed essential genes were confirmed
as being greatly enriched among genes with very high degree
(Fig 2E).
Predicting shared lineage and primary disease from cell
line signatures
Cell line profiles were taken from the transpose of the corrected
gene essentiality profile matrix, and pairs of cell lines were labeled
as deriving or not deriving from the same cell lineage. This created
436 choose 2 observations of 0 (different primary tissue) and 1
(same primary tissue). The same was done for secondary tissue.
ROC plots and AUC values on using correlation between cell line
profiles to detect lineage or primary disease identity were calculated
using the ROCR R package. The higher the accuracy, the better gene
profiles are able to expose differences across cell types in biological
pathway dependence.
TP53 and BRAF co-functionality heatmaps
Germline-filtered mutation data, such as for TP53 and BRAF, and
drug sensitivity data were downloaded from the CCLE portal
(https://portals.broadinstitute.org/ccle/data). For TP53, all cell
lines with a protein-coding or splice mutation were labeled loss-of-
function mutants. For BRAF, cell lines with a V600E protein change
were labeled V600E lines. Binarized drug sensitivity to either
Nutlin-3 or PLX4720 followed from k-means clustering on the Amax
values with k set to 2 to separate two groups of resistant and
sensitive.
The top 9 genes co-functional to either TP53 or BRAF were visu-
alized in the heatmap using the R package ComplexHeatmap.
Corrected gene essentiality profiles (rows) were divided by their
corresponding standard deviation to normalize the heat scale. The
distance metric for genes (rows) was magnitude of Pearson’s corre-
lation. For cell lines (columns), signed Pearson’s correlation was
used. Accompanying scatterplots show the unnormalized gene
knockout effect sizes with a linear fit trend line.
Drug–gene network and associations
The reported Amax values were used as measures of drug efficacy
for all cell lines. Drug phenotypes were then correlated with gene
knockout effect sizes for all drugs across all genes. For network
visualization (Fig 4D), the four genes with the largest magnitude
correlation in either direction were selected. For drug–gene
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association analysis (Fig 4E), the 30 most correlated gene profiles
were taken for KEGG pathway enrichment for each compound. Only
compounds with at least one enriched pathway were visualized.
Gene set enrichment comparisons
Curated gene sets derived from Gene Ontology and the Kyoto Ency-
clopedia of Genes and Genomes were downloaded from the MSigDB
website, version 6.1 (https://software.broadinstitute.org/gsea/
msigdb/). All pairs of human genes were assessed for co-annotation
by any ontology term. Aggregate enrichment of functional genes for
these co-annotated gene pairs (Fig 5A) was calculated as
log2 ðefc=ecÞ=ðef=eÞð Þ
where efc is the number of gene pairs that are both co-functional
and co-annotated, ec is the number of gene pairs that are co-anno-
tated, ef is the number of gene pairs that are co-functional, and e is
the number of total gene pairs.
Several gene sets consist primarily of essential genes with large
numbers of co-functional gene edges. Under these conditions, it is
possible for a small number of genes or pathways with a large
enrichment of co-functional gene edges to underlie a genome-wide
enrichment, even if most pathways contain few or no co-functional
genes. To estimate the number of gene sets contributing to the
aggregate enrichment, we first filtered out gene sets with under 5
co-functional gene edges. These low-signal, sparsely connected gene
sets are in some cases statistically enriched but would have limited
use in interpreting or modeling of genome-wide networks. The
remaining gene sets spanned slightly under half of GO biological
process and molecular function gene sets and approximately 70% of
GO cellular component and KEGG pathway sets.
Genes in the dataset were then placed into one of 100 bins based
on their degree in the co-functional gene network. For each gene
set, new, random gene sets were constructed such that each gene
was replaced by a random gene from the same degree bin. The
number of edges in the corresponding random subgraphs of the
genome-wide network was calculated to serve as an empirical null
distribution. If the random gene sets never reached the number of
edges seen in a true gene set, a P-value of 0.5/(# permutations) was
assigned to the gene set. Significantly enriched gene sets were called
at a false discovery rate of 5%. We found that over 75% of the
remaining GO biological process and molecular function terms
exhibited more edges than expected, and more than 90% of the
remaining GO cellular component and KEGG pathways.
Genetic interaction and protein complex comparisons
Protein–protein and genetic interaction data were downloaded from
the STRING v10.5 website (detailed and action files, https://string-db.
org/cgi/download.pl). Distances between gene pairs were calculated
using the distances function from the igraph R package. The rate at
which co-functional interactions were called per path length was calcu-
lated as (# co-functional interactions) divided by (# total gene pairs).
CORUM core complexes were downloaded from the CORUM
website (http://mips.helmholtz-muenchen.de/corum/#download).
A dataset of protein complex edges was created by enumerating all
pairs of genes that were members of the same human protein
complex. Among all such edges, 53.9% were called as co-functional.
The expected binomial distribution per complex (Fig 5D and E) was
calculated using the dbinom function in R, and 90% confidence
intervals were calculated using qbinom.
To calculate Mediator gene loadings and cell line PC scores,
PCA was performed on the corrected gene essentiality profiles of
Mediator complex members across 436 cell lines with the prcomp
function in R. With genes as features, the mean effect size of
each gene was subtracted to estimate the covariance across
genes. All loadings for the first principal component were posi-
tive, meaning all Mediator complex members covaried in the
same direction, and the magnitude of the loading was taken as
the relative weight for estimating the function of the entire
complex.
Community-centric analysis of the cancer cell network
Co-functional gene edges were analyzed using the igraph package in
R. Distances between two genes a and b were weighted by 1  abs
(cor(gene a, gene b)), and the edge width was scaled to abs(cor(-
gene a, gene b)). Communities were called using the cluster_in-
fomap function. The edge density of each community was
calculated by constructing a subgraph from the community
members and calling the edge_density function. In order to prevent
core essential genes from influencing measures of centrality, close-
ness was calculated for each gene locally by calling the closeness
function on the community subgraphs. The gene community
network plot (Fig 6A) was visualized by creating a new graph of
communities as nodes. Node area was made proportional to the
number of genes in the community by scaling the size parameter to
the square root of the number of genes. For gene communities with
greater than 100 genes, the community was discarded if more than
50% of the community’s genes laid on the same chromosome.
Edges were drawn between communities if the edge frequency
between them surpassed the genome-wide average of 0.98% with
width scaled to edge frequency.
Communities were annotated both by the number of members
that were COSMIC cancer census genes (https://cancer.sanger.ac.
uk/census) and by the enrichment in KEGG and Gene Ontology
gene sets as determined by the ClusterProfiler R package. Enrich-
ment of COSMIC census genes was determined by binomial test
with probability of success equal to the total number of COSMIC
census genes divided by the number of genes in the network and a
false discovery rate cutoff of 10%. Enrichment of uncharacterized
genes in gene clusters was determined similarly (Fig EV4), where
an uncharacterized gene was defined as any gene lacking a Gene
Ontology biological process annotation. To understand which
biological processes were sparsely connected and poorly repre-
sented (Fig EV3A), communities with fewer than 8 members were
analyzed using gene set enrichment.
The importance of the local closeness measure was first evaluated
using the Human Protein Atlas pathology data (https://www.proteina
tlas.org/about/download). For both favorable and unfavorable prog-
noses, genes were divided into four tiers: prognostic for 0, 1, 2, or 3+
cancer types. The Wilcoxon rank-sum test was used to compare local
closeness across tiers (Fig 7C). How probability of loss-of-function
intolerance (pLI) scores varied by closeness was also tested (http://
exac.broadinstitute.org/downloads, file “fordist_cleaned_exac_r03_
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march16_z_pli_rec_null_data.txt”), but was weakly predictive
compared to gene expression (Fig EV4A).
Gene community scores
Gene communities were processed by performing PCA on the
transpose of the corrected gene essentiality profile matrix and
recording the first principal component, as performed on the Medi-
ator complex. Cell lines were scored by their first principal compo-
nent score. Cell lines with large scores are interpreted as the
drivers of the gene community. To examine cancer lineage and
mutation status contributions to the NF1 gene community (Fig 7D),
community scores were aggregated by whether the cell lineage
was glioma and whether the cell line possessed a non-silent muta-
tion in NF1. To examine cancer lineage and mutation status contri-
bution to the KRAS gene community (Fig 7E), community scores
were aggregated by every lineage with more than 5 samples and
whether the cell line possessed a missense mutation in KRAS.
Significance of cell lineage contributions across all communities
(Fig EV5B) was determined by permuting cell lineage labels and
calculating mean community scores per cell lineage to generate a
null distribution. Cell lineages that had more extreme scores than
expected were called at a 5% FDR cutoff. The gene communities
with the thirty most significant associations were visualized.
Co-functional interaction examples
The chromosome idiogram in the gene regulation example was
downloaded from the Human Genome Idiogram Vector Art library
(https://github.com/RCollins13/HumanIdiogramLibrary). The chro-
mosome 17 idiogram ai file was chosen for illustration.
Data availability
Co-functional interactions are available at: https://greenleaf.shinya
pps.io/cofunctional_app_18Q4. The Shiny app code and full co-
functional interaction dataset with gene community information can
be downloaded from FigShare: https://figshare.com/s/35a82ed1e
48d0ec4e9e4.
Expanded View for this article is available online.
Acknowledgements
We thank Michael Haney and Michael Bassik for advice on CRISPR screen data
analysis. We also thank Eilon Sharon, Emily Glassberg, Nasa Sinnott-
Armstrong, and other Pritchard and Greenleaf lab members for helpful discus-
sions. This work was supported by the NIH (P50HG007735, RO1 HG008140,
1UM1HG009436), the Rita Allen Foundation, and the Human Frontiers Science
Program grant (RGY006S). Evan Boyle is supported by the National Science
Foundation Graduate Research Fellowship. William Greenleaf is an investigator
of the Chan Zuckerberg Biohub. Jonathan Pritchard is an investigator of the
Howard Hughes Medical Institute.
Author contributions
EAB conceived the project, performed analyses, and drafted the
manuscript. JKP and WJG supervised analyses. All authors edited and
revised the text.
Conflict of interest
The authors declare that they have no conflict of interest.
References
Aguirre AJ, Meyers RM, Weir BA, Vazquez F, Zhang C-Z, Ben-David U, Cook A,
Ha G, Harrington WF, Doshi MB, Kost-Alimova M, Gill S, Xu H, Ali LD, Jiang
G, Pantel S, Lee Y, Goodale A, Cherniack AD, Oh C et al (2016) Genomic
copy number dictates a gene-independent cell response to CRISPR/Cas9
targeting. Cancer Discov 6: 914 – 929
Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, Davis AP,
Dolinski K, Dwight SS, Eppig JT, Harris MA, Hill DP, Issel-Tarver L, Kasarskis
A, Lewis S, Matese JC, Richardson JE, Ringwald M, Rubin GM, Sherlock G
(2000) Gene ontology: tool for the unification of biology. The Gene
Ontology Consortium. Nat Genet 25: 25 – 29
Barabási A-L, Oltvai ZN (2004) Network biology: understanding the cell’s
functional organization. Nat Rev Genet 5: 101 – 113
Barabási A-L, Gulbahce N, Loscalzo J (2011) Network medicine: a network-
based approach to human disease. Nat Rev Genet 12: 56 – 68
Barretina J, Caponigro G, Stransky N, Venkatesan K, Margolin AA, Kim S,
Wilson CJ, Lehár J, Kryukov GV, Sonkin D, Reddy A, Liu M, Murray L, Berger
MF, Monahan JE, Morais P, Meltzer J, Korejwa A, Jané-Valbuena J, Mapa
FA et al (2012) The cancer cell line encyclopedia enables predictive
modelling of anticancer drug sensitivity. Nature 483: 603 – 607
Bassik MC, Kampmann M, Lebbink RJ, Wang S, Hein MY, Poser I, Weibezahn
J, Horlbeck MA, Chen S, Mann M, Hyman AA, LeProust EM, McManus MT,
Weissman JS (2013) A systematic mammalian genetic interaction map
reveals pathways underlying ricin susceptibility. Cell 152: 909 – 922
Bovée JVMG (2008) Multiple osteochondromas. Orphanet J Rare Dis 3: 3
Breeze CE, Paul DS, van Dongen J, Butcher LM, Ambrose JC, Barrett JE, Lowe
R, Rakyan VK, Iotchkova V, Frontini M, Downes K, Ouwehand WH, Laperle
J, Jacques P-É, Bourque G, Bergmann AK, Siebert R, Vellenga E, Saeed S,
Matarese F et al (2016) eFORGE: a tool for identifying cell type-specific
signal in epigenomic data. Cell Rep 17: 2137 – 2150
Clementz AG, Osipo C (2009) Notch versus the proteasome: what is the
target of gamma-secretase inhibitor-I? Breast Cancer Res 11: 110
Costanzo M, Baryshnikova A, Bellay J, Kim Y, Spear ED, Sevier CS, Ding H,
Koh JLY, Toufighi K, Mostafavi S, Prinz J, St Onge RP, VanderSluis B,
Makhnevych T, Vizeacoumar FJ, Alizadeh S, Bahr S, Brost RL, Chen Y,
Cokol M et al (2010) The genetic landscape of a cell. Science 327:
425 – 431
Costanzo M, VanderSluis B, Koch EN, Baryshnikova A, Pons C, Tan G, Wang
W, Usaj M, Hanchard J, Lee SD, Pelechano V, Styles EB, Billmann M, van
Leeuwen J, Van Dyk N, Lin Z-Y, Kuzmin E, Nelson J, Piotrowski JS, Srikumar
T et al (2016) A global genetic interaction network maps a wiring diagram
of cellular function. Science 353: aaf1420
Deshpande R, Nelson J, Simpkins SW, Costanzo M, Piotrowski JS, Li SC, Boone
C, Myers CL (2017) Efficient strategies for screening large-scale genetic
interaction networks. BioRxiv. https://doi.org/10.1101/159632 [PREPRINT]
Doench JG, Fusi N, Sullender M, Hegde M, Vaimberg EW, Donovan KF, Smith
I, Tothova Z, Wilen C, Orchard R, Virgin HW, Listgarten J, Root DE (2016)
Optimized sgRNA design to maximize activity and minimize off-target
effects of CRISPR-Cas9. Nat Biotechnol 34: 184 – 191
Fontana L, Partridge L, Longo VD (2010) Extending healthy life span-from
yeast to humans. Science 328: 321 – 326
Forbes SA, Beare D, Boutselakis H, Bamford S, Bindal N, Tate J, Cole CG, Ward
S, Dawson E, Ponting L, Stefancsik R, Harsha B, Kok CY, Jia M, Jubb H,
14 of 16 Molecular Systems Biology 14: e8594 | 2018 ª 2018 The Authors
Molecular Systems Biology Genetic screens elucidate cell networks Evan A Boyle et al
Sondka Z, Thompson S, De T, Campbell PJ (2017) COSMIC: somatic cancer
genetics at high-resolution. Nucleic Acids Res 45: D777 –D783
Fortunato S (2010) Community detection in graphs. Phys Rep 486: 75 – 174
Fraser HB, Plotkin JB (2007) Using protein complexes to predict phenotypic
effects of gene mutation. Genome Biol 8: R252
Gavory G, O’Dowd CR, Helm MD, Flasz J, Arkoudis E, Dossang A, Hughes C,
Cassidy E, McClelland K, Odrzywol E, Page N, Barker O, Miel H, Harrison T
(2018) Discovery and characterization of highly potent and selective
allosteric USP7 inhibitors. Nat Chem Biol 14: 118 – 125
Gilbert LA, Horlbeck MA, Adamson B, Villalta JE, Chen Y, Whitehead EH,
Guimaraes C, Panning B, Ploegh HL, Bassik MC, Qi LS, Kampmann M,
Weissman JS (2014) Genome-scale CRISPR-mediated control of gene
repression and activation. Cell 159: 647 – 661
Gilmore TD (2006) Introduction to NF-jB: players, pathways, perspectives.
Oncogene 25: 6680 – 6684
GTEx Consortium, Laboratory, Data Analysis &Coordinating Center (LDACC)—
Analysis Working Group, Statistical Methods groups—Analysis Working
Group, Enhancing GTEx (eGTEx) groups, NIH Common Fund, NIH/NCI,
NIH/NHGRI, NIH/NIMH, NIH/NIDA, Biospecimen Collection Source Site—
NDRI, Biospecimen Collection Source Site—RPCI, Biospecimen Core
Resource—VARI, Brain Bank Repository—University of Miami Brain
Endowment Bank, Leidos Biomedical—Project Management, ELSI Study,
Genome Browser Data Integration &Visualization—EBI, Genome Browser
Data Integration &Visualization—UCSC Genomics Institute, University of
California Santa Cruz, Lead analysts: Laboratory, Data Analysis
&Coordinating Center (LDACC): NIH program management et al (2017)
Genetic effects on gene expression across human tissues. Nature 550:
204 – 213
Gutmann DH, Ferner RE, Listernick RH, Korf BR, Wolters PL, Johnson KJ (2017)
Neurofibromatosis type 1. Nat Rev Dis Primers 3: 17004
Han K, Jeng EE, Hess GT, Morgens DW, Li A, Bassik MC (2017) Synergistic
drug combinations for cancer identified in a CRISPR screen for pairwise
genetic interactions. Nat Biotechnol 35: 463 – 474
Hart T, Brown KR, Sircoulomb F, Rottapel R, Moffat J (2014) Measuring error
rates in genomic perturbation screens: gold standards for human
functional genomics. Mol Syst Biol 10: 733
Hart T, Chandrashekhar M, Aregger M, Steinhart Z, Brown KR, MacLeod G,
Mis M, Zimmermann M, Fradet-Turcotte A, Sun S, Mero P, Dirks P, Sidhu
S, Roth FP, Rissland OS, Durocher D, Angers S, Moffat J (2015) High-
resolution CRISPR screens reveal fitness genes and genotype-specific
cancer liabilities. Cell 163: 1515 – 1526
Horlbeck MA, Xu A, Wang M, Bennett NK, Park CY, Bogdanoff D, Adamson B,
Chow ED, Kampmann M, Peterson TR, Nakamura K, Fischbach MA,
Weissman JS, Gilbert LA (2018) Mapping the genetic landscape of human
cells. Cell 174: 953 – 967.e22
Javierre BM, Burren OS, Wilder SP, Kreuzhuber R, Hill SM, Sewitz S, Cairns J,
Wingett SW, Várnai C, Thiecke MJ, Burden F, Farrow S, Cutler AJ,
Rehnström K, Downes K, Grassi L, Kostadima M, Freire-Pritchett P, Wang
F, BLUEPRINT Consortium et al (2016) Lineage-specific genome
architecture links enhancers and non-coding disease variants to target
gene promoters. Cell 167: 1369 – 1384.e19
Kampmann M, Horlbeck MA, Chen Y, Tsai JC, Bassik MC, Gilbert LA, Villalta JE,
Kwon SC, Chang H, Kim VN, Weissman JS (2015) Next-generation libraries
for robust RNA interference-based genome-wide screens. Proc Natl Acad
Sci USA 112: E3384 – E3391
Kim E, Dede M, Lenoir WF, Wang G, Srinivasan S, Colic M, Hart T (2018)
Hierarchical organization of the human cell from a cancer coessentiality
network. BioRxiv. https://doi.org/10.1101/328880 [PREPRINT]
Lek M, Karczewski KJ, Minikel EV, Samocha KE, Banks E, Fennell T, O’Donnell-
Luria AH, Ware JS, Hill AJ, Cummings BB, Tukiainen T, Birnbaum DP,
Kosmicki JA, Duncan LE, Estrada K, Zhao F, Zou J, Pierce-Hoffman E,
Berghout J, Cooper DN et al (2016) Analysis of protein-coding genetic
variation in 60,706 humans. Nature 536: 285 – 291
Lindsey S, Langhans SA (2015) Epidermal growth factor signaling in
transformed cells. Int Rev Cell Mol Biol 314: 1 –41
McFarland JM, Ho ZV, Kugener G, Dempster JM, Montgomery PG, Bryan JG,
Krill-Burger JM, Green TM, Vazquez F, Boehm JS, Golub TR, Hahn WC, Root
DE, Tsherniak A (2018) Improved estimation of cancer dependencies from
large-scale RNAi screens using model-based normalization and data
integration. Nat Commun 9: 4610
Medina PJ, Goodin S (2008) Lapatinib: a dual inhibitor of human epidermal
growth factor receptor tyrosine kinases. Clin Ther 30: 1426 – 1447
Meyers RM, Bryan JG, McFarland JM, Weir BA, Sizemore AE, Xu H, Dharia NV,
Montgomery PG, Cowley GS, Pantel S, Goodale A, Lee Y, Ali LD, Jiang G,
Lubonja R, Harrington WF, Strickland M, Wu T, Hawes DC, Zhivich VA
et al (2017) Computational correction of copy number effect improves
specificity of CRISPR-Cas9 essentiality screens in cancer cells. Nat Genet
49: 1779 – 1784
Meyers RM, Bryan JG, McFarland JM, Weir BA, Sizemore AE, Xu H, Dharia NV,
Montgomery PG, Cowley GS, Pantel S, Goodale A, Lee Y, Ali LD, Jiang G,
Lubonja R, Harrington WF, Strickland M, Wu T, Hawes DC, Zhivich VA
et al (2017). Project Achilles avana_public_18Q2, v2 (http://portals.b
roadinstitute.org/achilles/datasets/21/download) [DATASET]
Morgens DW, Wainberg M, Boyle EA, Ursu O, Araya CL, Tsui CK, Haney MS,
Hess GT, Han K, Jeng EE, Li A, Snyder MP, Greenleaf WJ, Kundaje A, Bassik
MC (2017) Genome-scale measurement of off-target activity using Cas9
toxicity in high-throughput screens. Nat Commun 8: 15178
Mumbach MR, Satpathy AT, Boyle EA, Dai C, Gowen BG, Cho SW, Nguyen ML,
Rubin AJ, Granja JM, Kazane KR, Wei Y, Nguyen T, Greenside PG, Corces
MR, Tycko J, Simeonov DR, Suliman N, Li R, Xu J, Flynn RA et al (2017)
Enhancer connectome in primary human cells identifies target genes of
disease-associated DNA elements. Nat Genet 49: 1602 – 1612
Ogasawara S, Kiyota Y, Chuman Y, Kowata A, Yoshimura F, Tanino K, Kamada
R, Sakaguchi K (2015) Novel inhibitors targeting PPM1D phosphatase
potently suppress cancer cell proliferation. Bioorg Med Chem 23:
6246 – 6249
Ornitz DM, Itoh N (2015) The fibroblast growth factor signaling pathway.
Wiley Interdiscip Rev Dev Biol 4: 215 – 266
Pan J, Meyers RM, Michel BC, Mashtalir N, Sizemore AE, Wells JN, Cassel SH,
Vazquez F, Weir BA, Hahn WC, Marsh JA, Tsherniak A, Kadoch C (2018)
Interrogation of mammalian protein complex structure, function, and
membership using genome-scale fitness screens. Cell Syst 6: 555 – 568.e7
Park RJ, Wang T, Koundakjian D, Hultquist JF, Lamothe-Molina P, Monel B,
Schumann K, Yu H, Krupzcak KM, Garcia-Beltran W, Piechocka-Trocha A,
Krogan NJ, Marson A, Sabatini DM, Lander ES, Hacohen N, Walker BD
(2017) A genome-wide CRISPR screen identifies a restricted set of HIV host
dependency factors. Nat Genet 49: 193 – 203
Pickrell JK, Marioni JC, Pai AA, Degner JF, Engelhardt BE, Nkadori E, Veyrieras
J-B, Stephens M, Gilad Y, Pritchard JK (2010) Understanding mechanisms
underlying human gene expression variation with RNA sequencing. Nature
464: 768 – 772
Pommier Y (2006) Topoisomerase I inhibitors: camptothecins and beyond.
Nat Rev Cancer 6: 789 – 802
Rauscher B, Heigwer F, Henkel L, Hielscher T, Voloshanenko O, Boutros M
(2018) Toward an integrated map of genetic interactions in cancer cells.
Mol Syst Biol 14: e7656
ª 2018 The Authors Molecular Systems Biology 14: e8594 | 2018 15 of 16
Evan A Boyle et al Genetic screens elucidate cell networks Molecular Systems Biology
Rhee SY, Wood V, Dolinski K, Draghici S (2008) Use and misuse of the gene
ontology annotations. Nat Rev Genet 9: 509 – 515
Roadmap Epigenomics Consortium, Kundaje A, Meuleman W, Ernst J, Bilenky
M, Yen A, Heravi-Moussavi A, Kheradpour P, Zhang Z, Wang J, Ziller MJ,
Amin V, Whitaker JW, Schultz MD, Ward LD, Sarkar A, Quon G, Sandstrom
RS, Eaton ML, Wu Y-C et al (2015) Integrative analysis of 111 reference
human epigenomes. Nature 518: 317 – 330
Rolland T, Tasan M, Charloteaux B, Pevzner SJ, Zhong Q, Sahni N, Yi S,
Lemmens I, Fontanillo C, Mosca R, Kamburov A, Ghiassian SD, Yang X,
Ghamsari L, Balcha D, Begg BE, Braun P, Brehme M, Broly MP, Carvunis A-
R et al (2014) A proteome-scale map of the human interactome network.
Cell 159: 1212 – 1226
Rosenbluh J, Xu H, Harrington W, Gill S, Wang X, Vazquez F, Root DE,
Tsherniak A, Hahn WC (2017) Complementary information derived from
CRISPR Cas9 mediated gene deletion and suppression. Nat Commun 8:
15403
Ruepp A, Waegele B, Lechner M, Brauner B, Dunger-Kaltenbach I, Fobo G,
Frishman G, Montrone C, Mewes H-W (2010) CORUM: the comprehensive
resource of mammalian protein complexes–2009. Nucleic Acids Res 38:
D497 –D501
Shalem O, Sanjana NE, Hartenian E, Shi X, Scott DA, Mikkelsen TS, Heckl D,
Ebert BL, Root DE, Doench JG, Zhang F (2014) Genome-scale CRISPR-Cas9
knockout screening in human cells. Science 343: 84 – 87
Shen JP, Zhao D, Sasik R, Luebeck J, Birmingham A, Bojorquez-Gomez A, Licon
K, Klepper K, Pekin D, Beckett AN, Sanchez KS, Thomas A, Kuo C-C, Du D,
Roguev A, Lewis NE, Chang AN, Kreisberg JF, Krogan N, Qi L et al (2017)
Combinatorial CRISPR-Cas9 screens for de novo mapping of genetic
interactions. Nat Methods 14: 573 – 576
Stumpf MPH, Thorne T, de Silva E, Stewart R, An HJ, Lappe M, Wiuf C (2008)
Estimating the size of the human interactome. Proc Natl Acad Sci USA 105:
6959 – 6964
Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA,
Paulovich A, Pomeroy SL, Golub TR, Lander ES, Mesirov JP (2005) Gene set
enrichment analysis: a knowledge-based approach for interpreting
genome-wide expression profiles. PNAS 102: 15545 – 15550
Szklarczyk D, Franceschini A, Wyder S, Forslund K, Heller D, Huerta-Cepas J,
Simonovic M, Roth A, Santos A, Tsafou KP, Kuhn M, Bork P, Jensen LJ, von
Mering C (2015) STRING v10: protein-protein interaction networks,
integrated over the tree of life. Nucleic Acids Res 43: D447 –D452
The Gene Ontology Consortium (2017) Expansion of the Gene Ontology
knowledgebase and resources. Nucleic Acids Res 45: D331 –D338
Timmons JA, Szkop KJ, Gallagher IJ (2015) Multiple sources of bias confound
functional enrichment analysis of global -omics data. Genome Biol 16: 186
Tong AHY, Lesage G, Bader GD, Ding H, Xu H, Xin X, Young J, Berriz GF, Brost
RL, Chang M, Chen Y, Cheng X, Chua G, Friesen H, Goldberg DS, Haynes J,
Humphries C, He G, Hussein S, Ke L et al (2004) Global mapping of the
yeast genetic interaction network. Science 303: 808 – 813
Uhlen M, Zhang C, Lee S, Sjöstedt E, Fagerberg L, Bidkhori G, Benfeitas R, Arif
M, Liu Z, Edfors F, Sanli K, von Feilitzen K, Oksvold P, Lundberg E, Hober S,
Nilsson P, Mattsson J, Schwenk JM, Brunnström H, Glimelius B et al (2017)
A pathology atlas of the human cancer transcriptome. Science 357:
eaan2507
Venkatesan K, Rual J-F, Vazquez A, Stelzl U, Lemmens I, Hirozane-Kishikawa
T, Hao T, Zenkner M, Xin X, Goh K-I, Yildirim MA, Simonis N, Heinzmann
K, Gebreab F, Sahalie JM, Cevik S, Simon C, de Smet A-S, Dann E, Smolyar
A et al (2009) An empirical framework for binary interactome mapping.
Nat Methods 6: 83 – 90
Wang T, Wei JJ, Sabatini DM, Lander ES (2014) Genetic screens in human
cells using the CRISPR-Cas9 system. Science 343: 80 – 84
Wang T, Birsoy K, Hughes NW, Krupczak KM, Post Y, Wei JJ, Lander ES,
Sabatini DM (2015) Identification and characterization of essential genes
in the human genome. Science 350: 1096 – 1101
Wang T, Yu H, Hughes NW, Liu B, Kendirli A, Klein K, Chen WW, Lander ES,
Sabatini DM (2017) Gene essentiality profiling reveals gene networks and
synthetic lethal interactions with oncogenic ras. Cell 168: 890 – 903.e15
Wong ASL, Choi GCG, Cui CH, Pregernig G, Milani P, Adam M, Perli SD, Kazer
SW, Gaillard A, Hermann M, Shalek AK, Fraenkel E, Lu TK (2016)
Multiplexed barcoded CRISPR-Cas9 screening enabled by CombiGEM. Proc
Natl Acad Sci USA 113: 2544 – 2549
Wu A, Xiao T, Fei T, Liu SX, Li W (2018) Reducing false positives in CRISPR/
Cas9 screens from copy number variations. BioRxiv. https://doi.org/10.1101/
247031 [PREPRINT]
Yin J-W, Wang G (2014) The Mediator complex: a master coordinator of
transcription and cell lineage development. Development 141: 977 – 987
Zhang Y, Lu H (2009) Signaling to p53: ribosomal proteins find their way.
Cancer Cell 16: 369 – 377
License: This is an open access article under the
terms of the Creative Commons Attribution 4.0
License, which permits use, distribution and reproduc-
tion in any medium, provided the original work is
properly cited.
16 of 16 Molecular Systems Biology 14: e8594 | 2018 ª 2018 The Authors
Molecular Systems Biology Genetic screens elucidate cell networks Evan A Boyle et al
